|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q92301402
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010859.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q92301402
|
|
024
|
|
|
‡a
7102381210
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q92301402
|
|
100
|
0 |
|
‡a
Jannet M. Carmichael
‡c
pharmaceutical researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Jannet M. Carmichael
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A suite of inpatient and outpatient clinical measures for pharmacy accountability: recommendations from the Pharmacy Accountability Measures Work Group
|
|
670
|
|
|
‡a
Author's Academic Detailing to Improve Opioid Safety: Implementation Lessons from a Qualitative Evaluation
|
|
670
|
|
|
‡a
Author's An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical C
|
|
670
|
|
|
‡a
Author's ASHP reports. A powerful, likely story
|
|
670
|
|
|
‡a
Author's Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?
|
|
670
|
|
|
‡a
Author's Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers
|
|
670
|
|
|
‡a
Author's Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy
|
|
670
|
|
|
‡a
Author's Comparing fracture absolute risk assessment (FARA) tools: an osteoporosis clinical informatics tool to improve identification and care of men at high risk of first fracture
|
|
670
|
|
|
‡a
Author's Determinants of Treatment Eligibility in Veterans With Hepatitis C Viral Infection
|
|
670
|
|
|
‡a
Author's Do pharmacists need prescribing privileges to implement pharmaceutical care?
|
|
670
|
|
|
‡a
Author's Effect of clinical pharmacy input on physician prescribing habits in the nursing home care unit
|
|
670
|
|
|
‡a
Author's Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function
|
|
670
|
|
|
‡a
Author's Emergency-room services for a community health center
|
|
670
|
|
|
‡a
Author's Establishment and outcomes of a model primary care pharmacy service system
|
|
670
|
|
|
‡a
Author's Evaluating the Impact of a Clinical Decision Support Tool to Reduce Chronic Opioid Dose and Decrease Risk Classification in a Veteran Population
|
|
670
|
|
|
‡a
Author's Evaluation of allopurinol use in patients with gout
|
|
670
|
|
|
‡a
Author's Evolution of ambulatory care pharmacy practice in the past 50 years
|
|
670
|
|
|
‡a
Author's Healthcare metrics: Where do pharmacists add value?
|
|
670
|
|
|
‡a
Author's Improvement of competence after preparation for board certification examination
|
|
670
|
|
|
‡a
Author's Improving patient care and demonstrating value during a global pandemic: Recommendations from leaders of the Pharmacy Accountability Measures Work Group
|
|
670
|
|
|
‡a
Author's Interpreting the findings of the IMPROVE study.
|
|
670
|
|
|
‡a
Author's Leveraging electronic medical record data for population health management in the Veterans Health Administration: Successes and lessons learned
|
|
670
|
|
|
‡a
Author's Medical recommendations for wilderness travel. 1. Health maintenance in the great outdoors
|
|
670
|
|
|
‡a
Author's Medical recommendations for wilderness travel. 2. Field management of illness and injury
|
|
670
|
|
|
‡a
Author's Medical recommendations for wilderness travel. 3. Medical supplies and drug regimens
|
|
670
|
|
|
‡a
Author's New perspectives on glaucoma screening
|
|
670
|
|
|
‡a
Author's Pharmacist privileging in a health system: Report of the Qualified Provider Model Ad Hoc Committee
|
|
670
|
|
|
‡a
Author's Pharmacy's bucket list: lean in.
|
|
670
|
|
|
‡a
Author's Rational approach to long-term use of H2-antagonists
|
|
670
|
|
|
‡a
Author's Recommended quality measures for health-system pharmacy: 2019 update from the Pharmacy Accountability Measures Work Group
|
|
670
|
|
|
‡a
Author's Reduced quality of life in veterans at risk for drug-related problems
|
|
670
|
|
|
‡a
Author's Survey of ulcer-recurrence risk factors associated with long-term cimetidine prescribing
|
|
670
|
|
|
‡a
Author's The changing role of pharmacy practice--a clinical perspective
|
|
670
|
|
|
‡a
Author's Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers
|
|
670
|
|
|
‡a
Author's Understanding infertility treatment plans.
|
|
909
|
|
|
‡a
(scopus) 7102381210
‡9
1
|
|
919
|
|
|
‡a
effectofclinicalpharmacyinputonphysicianprescribinghabitsinthenursinghomecareunit
‡A
Effect of clinical pharmacy input on physician prescribing habits in the nursing home care unit
‡9
1
|
|
919
|
|
|
‡a
determinantsoftreatmenteligibilityinveteranswithhepatitis100viralinfection
‡A
Determinants of Treatment Eligibility in Veterans With Hepatitis C Viral Infection
‡9
1
|
|
919
|
|
|
‡a
comparingfractureabsoluteriskassessmentfaratoolsanosteoporosisclinicalinformaticstooltoimproveidentificationandcareofmenathighriskof1fracture
‡A
Comparing fracture absolute risk assessment (FARA) tools: an osteoporosis clinical informatics tool to improve identification and care of men at high risk of first fracture
‡9
1
|
|
919
|
|
|
‡a
collaborativedrugtherapymanagementbypharmacistsamericancollegeofclinicalpharmacy
‡A
Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy
‡9
1
|
|
919
|
|
|
‡a
clinicalandeconomicimpactofambulatorycareclinicalpharmacistsinmanagementofdyslipidemiainolderadultstheimprovestudyimpactofmanagedpharmaceuticalcareonresourceutilizationandoutcomesinveteransaffairsmedicalcenters
‡A
Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers
‡9
1
|
|
919
|
|
|
‡a
canclinicalpharmacistsaffectsf36scoresinveteransathighriskformedicationrelatedproblems
‡A
Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?
‡9
1
|
|
919
|
|
|
‡a
ashpreports
‡A
ASHP reports. A powerful, likely story
‡9
1
|
|
919
|
|
|
‡a
economicanalysisofarandomizedcontrolledmulticenterstudyofclinicalpharmacistinterventionsforhighriskveteranstheimprovestudyimpactofmanagedpharmaceuticalcareresourceutilizationandoutcomesinveteransaffairsmedical100
‡A
An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical C
‡9
1
|
|
919
|
|
|
‡a
academicdetailingtoimproveopioidsafetyimplementationlessonsfromaqualitativeevaluation
‡A
Academic Detailing to Improve Opioid Safety: Implementation Lessons from a Qualitative Evaluation
‡9
1
|
|
919
|
|
|
‡a
suiteofinpatientandoutpatientclinicalmeasuresforpharmacyaccountabilityrecommendationsfromthepharmacyaccountabilitymeasuresworkgroup
‡A
A suite of inpatient and outpatient clinical measures for pharmacy accountability: recommendations from the Pharmacy Accountability Measures Work Group
‡9
1
|
|
919
|
|
|
‡a
establishmentandoutcomesofamodelprimarycarepharmacyservicesystem
‡A
Establishment and outcomes of a model primary care pharmacy service system
‡9
1
|
|
919
|
|
|
‡a
evaluatingtheimpactofaclinicaldecisionsupporttooltoreducechronicopioiddoseanddecreaseriskclassificationinaveteranpopulation
‡A
Evaluating the Impact of a Clinical Decision Support Tool to Reduce Chronic Opioid Dose and Decrease Risk Classification in a Veteran Population
‡9
1
|
|
919
|
|
|
‡a
evaluationofallopurinoluseinpatientswithgout
‡A
Evaluation of allopurinol use in patients with gout
‡9
1
|
|
919
|
|
|
‡a
evolutionofambulatorycarepharmacypracticeinthepast50years
‡A
Evolution of ambulatory care pharmacy practice in the past 50 years
‡9
1
|
|
919
|
|
|
‡a
healthcaremetricswheredopharmacistsaddvalue
‡A
Healthcare metrics: Where do pharmacists add value?
‡9
1
|
|
919
|
|
|
‡a
improvementofcompetenceafterpreparationforboardcertificationexamination
‡A
Improvement of competence after preparation for board certification examination
‡9
1
|
|
919
|
|
|
‡a
improvingpatientcareanddemonstratingvalueduringaglobalpandemicrecommendationsfromleadersofthepharmacyaccountabilitymeasuresworkgroup
‡A
Improving patient care and demonstrating value during a global pandemic: Recommendations from leaders of the Pharmacy Accountability Measures Work Group
‡9
1
|
|
919
|
|
|
‡a
interpretingthefindingsoftheimprovestudy
‡A
Interpreting the findings of the IMPROVE study.
‡9
1
|
|
919
|
|
|
‡a
leveragingelectronicmedicalrecorddataforpopulationhealthmanagementintheveteranshealthadministrationsuccessesandlessonslearned
‡A
Leveraging electronic medical record data for population health management in the Veterans Health Administration: Successes and lessons learned
‡9
1
|
|
919
|
|
|
‡a
medicalrecommendationsforwildernesstravel1healthmaintenanceinthegreatoutdoors
‡A
Medical recommendations for wilderness travel. 1. Health maintenance in the great outdoors
‡9
1
|
|
919
|
|
|
‡a
medicalrecommendationsforwildernesstravel2fieldmanagementofillnessandinjury
‡A
Medical recommendations for wilderness travel. 2. Field management of illness and injury
‡9
1
|
|
919
|
|
|
‡a
medicalrecommendationsforwildernesstravel3medicalsuppliesanddrugregimens
‡A
Medical recommendations for wilderness travel. 3. Medical supplies and drug regimens
‡9
1
|
|
919
|
|
|
‡a
newperspectivesonglaucomascreening
‡A
New perspectives on glaucoma screening
‡9
1
|
|
919
|
|
|
‡a
pharmacistprivileginginahealthsystemreportofthequalifiedprovidermodeladhoccommittee
‡A
Pharmacist privileging in a health system: Report of the Qualified Provider Model Ad Hoc Committee
‡9
1
|
|
919
|
|
|
‡a
pharmacysbucketlistleanin
‡A
Pharmacy's bucket list: lean in.
‡9
1
|
|
919
|
|
|
‡a
rationalapproachtolongtermuseofh2antagonists
‡A
Rational approach to long-term use of H2-antagonists
‡9
1
|
|
919
|
|
|
‡a
recommendedqualitymeasuresforhealthsystempharmacy2019updatefromthepharmacyaccountabilitymeasuresworkgroup
‡A
Recommended quality measures for health-system pharmacy: 2019 update from the Pharmacy Accountability Measures Work Group
‡9
1
|
|
919
|
|
|
‡a
reducedqualityoflifeinveteransatriskfordrugrelatedproblems
‡A
Reduced quality of life in veterans at risk for drug-related problems
‡9
1
|
|
919
|
|
|
‡a
surveyofulcerrecurrenceriskfactorsassociatedwithlongtermcimetidineprescribing
‡A
Survey of ulcer-recurrence risk factors associated with long-term cimetidine prescribing
‡9
1
|
|
919
|
|
|
‡a
changingroleofpharmacypracticeaclinicalperspective
‡A
The changing role of pharmacy practice--a clinical perspective
‡9
1
|
|
919
|
|
|
‡a
typesofinterventionsmadebyclinicalpharmacistsintheimprovestudyimpactofmanagedpharmaceuticalcareonresourceutilizationandoutcomesinveteransaffairsmedicalcenters
‡A
Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers
‡9
1
|
|
919
|
|
|
‡a
understandinginfertilitytreatmentplans
‡A
Understanding infertility treatment plans.
‡9
1
|
|
919
|
|
|
‡a
dopharmacistsneedprescribingprivilegestoimplementpharmaceuticalcare
‡A
Do pharmacists need prescribing privileges to implement pharmaceutical care?
‡9
1
|
|
919
|
|
|
‡a
emergencyroomservicesforacommunityhealthcenter
‡A
Emergency-room services for a community health center
‡9
1
|
|
919
|
|
|
‡a
effectsofnonsteroidalantiinflammatorydrugsonprostaglandinsandrenalfunction
‡A
Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
CAOONL|ncf10001636
|
|
996
|
|
|
‡2
CAOONL|ncf10380685
|
|
996
|
|
|
‡2
J9U|987007330443005171
|
|
996
|
|
|
‡2
RERO|A003077932
|
|
996
|
|
|
‡2
CAOONL|ncf10112961
|
|
996
|
|
|
‡2
N6I|vtls002761159
|
|
996
|
|
|
‡2
CAOONL|ncf10089192
|
|
996
|
|
|
‡2
BIBSYS|2034851
|
|
996
|
|
|
‡2
NTA|10392373X
|
|
996
|
|
|
‡2
NII|DA07956015
|
|
996
|
|
|
‡2
SUDOC|259304980
|
|
996
|
|
|
‡2
LC|n 81067128
|
|
996
|
|
|
‡2
N6I|vtls000073381
|
|
996
|
|
|
‡2
NTA|068304242
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
